The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients "EMOTION"
Recruiting
Phase 4 Results N/ASummary of Purpose
Through this study, the investigators are to demonstrate the superiority of Escitalopram over placebo for the prevention of poststroke depression in patients with acute stroke The primary hypothesis of this study is; This study will prove the superiority of Escitalopram on the prevention of poststroke depression in patients with acute stroke against placebo
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 25 January 2012.
| 1 Jan 2011 | 18 Jan 2011 | 1 Dec 2013 | 1 Dec 2013 | 1 Jan 2011 | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
- Purpose: Prevention
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
Contacts
- Jong Sung Kim, MD,PhD
jongskim@amc.seoul.kr 82-2-3010-3442
View Trial Locations
Recruitment
- Enrollment: 444
- Gender: Both
- Minimum Age: 20 Years
- Accepts Healthy Volunteers: No
- 14 locations, 1 country
Principal Investigator
- Jong Sung Kim, MD, PhD
Department of Neurology, Asan Medical Center
